ABVC BioPharma (ABVC) is scheduled to report Q1 earnings on May 12, 2026.
ABVC BioPharma has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, ABVC BioPharma has averaged an EPS surprise of 27.08% and a revenue surprise of 14.84%.
Analyze the earnings history of ABVC BioPharma using advanced sorting and filters.
The chart below shows ABVC BioPharma's reported EPS compared to analyst estimates over recent quarters.
The chart below shows ABVC BioPharma's reported revenue compared to analyst estimates over recent quarters.
ABVC BioPharma (ABVC) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on March 3, 2026 for Q4.
The Actual EPS was $-0.16, which missed the estimate of $0.00.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2023-08-14 | $-0.68 | $-0.60 | -1333.3 % |
| Q1 | 2023-05-15 | $-0.60 | $-0.50 | -2000.0 % |
| Q4 | 2023-03-31 | $-1.50 | $-1.50 | 0.00 % |
| Q3 | 2021-11-15 | $-0.70 | $-0.40 | -7500.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2023-08-14 | $6.11K | $300.00K | -98.0 % |
| Q1 | 2023-05-15 | $128.27K | $128.00K | 0.21 % |
| Q4 | 2023-03-31 | $588.99K | $10.00K | 5789.9 % |
| Q3 | 2021-11-15 | $99.00K | $190.00K | -47.9 % |